Are you a pharmacist experienced in managing chemotherapy induced nausea and vomiting?

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review the eLearning content for CINV. If you are currently managing policies related to CINV, have a minimum experience of 3 years in oncology, we would be delighted to have you apply as a reviewer.

As part of this important role we kindly request you to provide the following details:

Your current role and title:
Place of work: 

Additionally, we ask that you submit a brief statement (no more than 300 words) explaining why you are well suited for this role.

Your insights and expertise are crucial in ensuring the quality and relevance of our content.

To apply, please email [email protected]. Please note, applications will close on Monday 16th September and we will let candidates know the outcome by 21st September.

The selected reviewer will be remunerated for their valuable time and dedication to this initiative. We understand the significance of your contributions and as a token of appreciation, the reviewer will be acknowledged on our website.

Thank you for considering this opportunity, and we appreciate your continued dedication to enhancing healthcare knowledge.

Best wishes,

BOPA eLearning Team

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article